[Place of saluretics in the treatment of hypertension].
D000222:Adaptation, Physiological / Q000187:drug effects; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001581:Benzothiadiazines; D003692:Delayed-Action Preparations; D004232:Diuretics / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005665:Furosemide / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D000451:Mineralocorticoid Receptor Antagonists; D009318:Natriuresis / Q000187:drug effects*; D018377:Neurotransmitter Agents / Q000502:physiology; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D003692:Delayed-Action Preparations; D004232:Diuretics; D004338:Drug Combinations; D000451:Mineralocorticoid Receptor Antagonists; D018377:Neurotransmitter Agents; D049993:Sodium Chloride Symporter Inhibitors; D013148:Spironolactone; D005665:Furosemide
Mesto saluretikov v lechenii gipertonicheskoĭ bolezni